Avenue Therapeutics (ATXI) Financials

$0.62

$0.25 (65.33%)

As on 11-Sep-2026 15:48EDT

Market cap

$2 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

4.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	1.40	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	-1.40	1.40	--	--	--	--
Operating Expenses	3.10	4.69	11.28	14.54	8.04	3.74
Operating Profit (EBIT)	-3.10	-3.29	-11.28	-14.54	-8.04	-3.74
Other Income	--	--	--	--	--	--
Profit before Tax	-2.80	-2.95	-11.70	-10.49	-3.60	-3.73
Provision for Tax	--	--	--	-0.11	-5.65	-0.01
Profit after Tax (Net Income)	-2.78	-2.91	-11.65	-10.38	-3.55	-3.72
Minority Interest	0.03	0.04	0.04	0.11	0.05	--
Consolidated Profit	--	--	--	--	--	-3.73

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	0.57	1.83	2.80	1.58	3.91	3.45
Minority Interest	0.03	--	--	--	--	--
Non-Current Liabilities	--	--	--	--	--	0.36
Current Liabilities	1.41	1.10	0.82	1.20	3.58	0.51
Total Liabilities	3.38	2.93	2.67	1.85	6.85	3.96

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	--	--	--	0.07	0.14	--
Current Assets	1.94	2.86	2.67	1.85	6.85	3.96
Total Assets	3.35	2.93	2.67	1.85	6.85	3.96
Total Debt*	--	--	--	--	--	--
Net Current Assets	0.57	1.83	1.86	0.65	3.27	3.45

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-1.83	-9.03	-9.45	-7.60	-3.75
Cash Flow from Investing Activities	--	--	--	-3.00	--	--
Cash from Financing Activities	--	2.09	9.84	7.53	10.54	4.38
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.86	-0.93	-7.28	-0.41	-2.53	-3.06
Cash EPS ($)	-0.86	-0.93	-7.28	-0.41	-2.53	-3.06
Adjusted Book Value ($)	0.17	0.59	1.75	0.06	2.78	2.84
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.59	-5.64	-0.37	-5.40	-3.08
Free Cash Flow per Share ($)	--	-0.59	-5.64	-0.49	-5.40	-3.08

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-125.69	-532.18	-378.24	-96.57	-128.19
ROE (%)	-229.15	-125.69	-532.18	-378.24	-96.57	-128.19
ROA (%)	-62.84	-103.84	-515.35	-238.69	-65.75	-103.37
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	-207.19	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	--	--	--	9.94	-211.56	28.29
Net Profit Growth (%)	54.89	75.03	-12.29	-192.15	4.62	26.82
EPS Growth (%)	74.71	0.87	-16.96	0.84	0.17	0.34
Book Value Growth (%)	-86.45	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	--	-0.27	-0.40	-0.46	-0.30
Price / Book Value	4.77	--	1.14	2.61	0.42	0.32
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.42	--	-0.05	0.58	2.08	0.71
Close Price ($)	--	--	2.00	0.16	1.16	13.62
High Price ($)	--	--	8.99	2.35	18.75	115.35
Low Price ($)	--	--	0.09	0.13	1.06	13.20
Market Cap ($ Cr)	1.98	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	1.38	2.60	3.27	1.55	1.91	7.78
Quick Ratio	1.38	--	--	--	--	7.57
Interest Coverage	--	--	--	-31.59	-10.04	-534.00

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	0.50	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.